| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656720 | 43523 | DEPRELIO 25 mg CAPSULAS DURAS | DEPRELIO 25 mg CAPSULAS DURAS , 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/43523/43523_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/43523/43523_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 953 | LABORATORIO ALDO UNION S.L. | 1966-10-01 | 1 | 1 | 1 | 1966-10-01 | 2008-01-16 | 0 | 2012-01-02 | 790733 | View Edit Delete | |||||||||||
| 656800 | 68618 | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68618/68618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68618/68618_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 20478 | UXA FARMA S.A. | 2007-03-28 | 1 | 1 | 1 | 2007-03-28 | 2007-03-28 | 1 | 2011-10-03 | 658768 | View Edit Delete | |||||||||||
| 654681 | 41161 | VARIDASA COMPRIMIDOS | VARIDASA COMPRIMIDOS, 40 comprimidos | 10.000 UI/2.500 UI | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41161/41161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41161/41161_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 1965-06-01 | 1 | 1 | 1 | 1965-06-01 | 1998-03-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658126 | 68254 | MOMETASONA KORHISPANA 0,1% SOLUCION CUTANEA EFG | MOMETASONA KORHISPANA 0,1% SOLUCION CUTANEA EFG, 1 frasco de 60 ml | 1 mg/g | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68254/68254_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68254/68254_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10651 | KORHISPANA S.L. | 2006-12-14 | 1 | 1 | 1 | 2006-12-14 | 2006-12-14 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 656340 | 68153 | XAZAL 0,5 mg/ml SOLUCION ORAL | XAZAL 0,5 mg/ml SOLUCION ORAL, 1 frasco de 200 ml | 0,5 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68153/68153_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68153/68153_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21333 | UCB PHARMA S.A. | 2006-11-08 | 1 | 1 | 1 | 2006-11-08 | 2006-11-08 | 1 | 2011-05-04 | View Edit Delete | ||||||||||||
| 654778 | 22903 | VITAMINA D3 KERN PHARMA 2.000 UI/ml SOLUCION ORAL | VITAMINA D3 KERN PHARMA 2.000 UI/ml SOLUCION ORAL, 1 frasco de 10 ml (cuentagotas) | 2.000 UI/ml | 6 | 10 | 26 | 1 frasco de 10 ml (cuentagotas) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/22903/22903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/22903/22903_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1955-02-01 | 1 | 1 | 1 | 1955-02-01 | 2013-06-20 | 1 | 2014-01-02 | 725994, 663220 | View Edit Delete | |||||||||||
| 658336 | 62162 | MADOPAR RETARD 100/25 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | MADOPAR RETARD 100/25 mg CAPSULAS DURAS DE LIBERACION PROLONGADA, 100 cápsulas | 100 mg/25 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62162/62162_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62162/62162_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 24369 | ROCHE FARMA S.A. | 2001-08-17 | 1 | 1 | 1 | 2001-08-17 | 2001-08-17 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 655456 | 50883 | FLUIDIN MUCOLITICO 50 MG/ML SOLUCION ORAL | FLUIDIN MUCOLITICO 50 MG/ML SOLUCION ORAL , 1 frasco de 200 ml | 50 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50883/50883_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50883/50883_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10392 | LABORATORIOS VERIS S.A. | 1972-12-01 | 1 | 1 | 1 | 1972-12-01 | 1998-09-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 656353 | 68162 | METRONIDAZOL SERRACLINICS 5mg/ml SOLUCION PARA PERFUSION EFG | METRONIDAZOL SERRACLINICS 5mg/ml SOLUCION PARA PERFUSION EFG, 1 frasco de 100 ml | 500 mg | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68162/68162_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68162/68162_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2006-11-15 | 1 | 1 | 1 | 2006-11-15 | 2006-11-15 | 1 | 2014-10-29 | View Edit Delete | ||||||||||||
| 656914 | 68788 | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas | 20 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68788/68788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68788/68788_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2007-05-11 | 1 | 1 | 1 | 2007-05-11 | 2009-05-26 | 1 | 2011-10-21 | 659028 | View Edit Delete | |||||||||||
| 656915 | 68788 | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68788/68788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68788/68788_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2007-05-11 | 1 | 1 | 1 | 2007-05-11 | 2009-05-26 | 1 | 2011-10-21 | 659030 | View Edit Delete | |||||||||||
| 656917 | 69211 | OMEPRAZOL TARBIS FARMA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL TARBIS FARMA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69211/69211_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69211/69211_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2007-08-09 | 1 | 1 | 1 | 2007-08-13 | 2009-05-26 | 1 | 2011-10-21 | 659760 | View Edit Delete | |||||||||||
| 656012 | 66020 | IBUPROFENO CINFA 20 MG/ML SUSPENSIÓN ORAL EFG | IBUPROFENO CINFA 20 MG/ML SUSPENSIÓN ORAL EFG 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66020/66020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66020/66020_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2004-04-06 | 1 | 1 | 1 | 2004-04-06 | 2006-09-20 | 1 | 2011-10-19 | 890863 | View Edit Delete | |||||||||||
| 656148 | 68076 | PANTOPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos (frasco) | 40 mg | 6 | 14 | 10 | 14 comprimidos (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68076/68076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68076/68076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2006-10-09 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656149 | 68076 | PANTOPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (frasco) | 40 mg | 6 | 28 | 10 | 28 comprimidos (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68076/68076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68076/68076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2006-10-09 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656565 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2007-07-02 | 1 | 2011-09-09 | 655964 | View Edit Delete | |||||||||||
| 656738 | 50880 | FOSFOCINA 250 MG/5 ML POLVO PARA SUSPENSION ORAL | FOSFOCINA 250 MG/5 ML POLVO PARA SUSPENSION ORAL, 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50880/50880_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50880/50880_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1972-12-01 | 1 | 1 | 1 | 1972-12-01 | 2007-12-17 | 1 | 2011-09-09 | 759670 | View Edit Delete | |||||||||||
| 658228 | 68318 | PARACETAMOL LEVEL 100 mg/ml SOLUCION ORAL EFG | PARACETAMOL LEVEL 100 mg/ml SOLUCION ORAL EFG, 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68318/68318_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68318/68318_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2007-01-09 | 1 | 1 | 1 | 2007-01-09 | 2007-01-09 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 658230 | 68318 | PARACETAMOL LEVEL 100 mg/ml SOLUCION ORAL EFG | PARACETAMOL LEVEL 100 mg/ml SOLUCION ORAL EFG, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68318/68318_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68318/68318_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2007-01-09 | 1 | 1 | 1 | 2007-01-09 | 2007-01-09 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 655837 | 58828 | MASTICAL 500 mg COMPRIMIDOS MASTICABLES | MASTICAL 500 mg COMPRIMIDOS MASTICABLES, 90 comprimidos | 1.250 mg (500 mg Ca) | 6 | 90 | 10 | 90 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58828/58828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58828/58828_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1990-12-01 | 1 | 1 | 1 | 1990-12-01 | 1998-07-01 | 1 | 2011-09-13 | View Edit Delete |
Page 127 of 1035, showing 20 records out of 20697 total, starting on record 2521, ending on 2540